Literature DB >> 29846552

Ciprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosa.

Hannah Jedrey1, Kathryn S Lilley1, Martin Welch1.   

Abstract

Ciprofloxacin is one of the most widely-used antibiotics, and has proven especially effective at controlling infections associated with the opportunistic human pathogen, Pseudomonas aeruginosa. In this work, we show that sub-inhibitory concentrations of ciprofloxacin induce discrete changes in the intracellular proteome. Central metabolism and cell envelope-associated functions are particularly affected. In spite of the low magnitude of the intracellular proteomic changes, we found that sub-lethal concentrations of ciprofloxacin had substantial effects on motility and exoprotein secretion. Crucially, the proteomic and phenotypic modulations that we observed were absolutely dependent upon the presence of wild-type GyrA; an isogenic strain of P. aeruginosa carrying a ciprofloxacin-insensitive form of GyrA (a T83→I mutant) did not display ciprofloxacin-dependent changes unless complemented with wild-type gyrA in trans. These results show that the diverse effects of sub-inhibitory ciprofloxacin on the cell are routed through its primary target in the cell, DNA gyrase.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29846552      PMCID: PMC5995189          DOI: 10.1093/femsle/fny134

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  20 in total

1.  Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.

Authors:  Hannah G Stickland; Peter W Davenport; Kathryn S Lilley; Julian L Griffin; Martin Welch
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

Review 2.  The world of subinhibitory antibiotic concentrations.

Authors:  Julian Davies; George B Spiegelman; Grace Yim
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

Review 3.  DNA supercoiling is a fundamental regulatory principle in the control of bacterial gene expression.

Authors:  Charles J Dorman; Matthew J Dorman
Journal:  Biophys Rev       Date:  2016-06-16

Review 4.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

5.  A common mechanism of cellular death induced by bactericidal antibiotics.

Authors:  Michael A Kohanski; Daniel J Dwyer; Boris Hayete; Carolyn A Lawrence; James J Collins
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

6.  Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa.

Authors:  S E West; H P Schweizer; C Dall; A K Sample; L J Runyen-Janecky
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

7.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

Review 8.  Mechanism of action of and resistance to quinolones.

Authors:  Anna Fàbrega; Sergi Madurga; Ernest Giralt; Jordi Vila
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

9.  The tricarboxylic acid cycle, an ancient metabolic network with a novel twist.

Authors:  Ryan J Mailloux; Robin Bériault; Joseph Lemire; Ranji Singh; Daniel R Chénier; Robert D Hamel; Vasu D Appanna
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

Review 10.  NADPH-generating systems in bacteria and archaea.

Authors:  Sebastiaan K Spaans; Ruud A Weusthuis; John van der Oost; Servé W M Kengen
Journal:  Front Microbiol       Date:  2015-07-29       Impact factor: 5.640

View more
  4 in total

1.  Streptozotocin-Induced Hyperglycemia Is Associated with Unique Microbiome Metabolomic Signatures in Response to Ciprofloxacin Treatment.

Authors:  Jenna I Wurster; Rachel L Peterson; Peter Belenky
Journal:  Antibiotics (Basel)       Date:  2022-04-27

2.  A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics.

Authors:  Franziska Kampshoff; Mark D P Willcox; Debarun Dutta
Journal:  Antibiotics (Basel)       Date:  2019-05-09

3.  Detection of virulence and multidrug resistance operons in Pseudomonas aeruginosa isolated from Egyptian Baladi sheep and goat.

Authors:  A N Dapgh; A S Hakim; H A Abouelhag; A M Abdou; E A Elgabry
Journal:  Vet World       Date:  2019-10-04

4.  Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa.

Authors:  Xinyuan Feng; Zhiqi Zhang; Xiaoxia Li; Yan Song; Jianbang Kang; Donghong Yin; Yating Gao; Nan Shi; Jinju Duan
Journal:  Infect Drug Resist       Date:  2019-02-08       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.